Internal Medicine, Endocrinology, Diabetes, & Metabolism · Shavano Park, TX
NPI
1891764957
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4118 Pond Hill Rd, Suite 300
Shavano Park, TX, 78231
Phone (210) 494-3739
Groups this clinician bills Medicare through
Medicare paid, 2024
$382K
6,721 services
Medicare patients, 2024
750
Average age 74
Drug cost, 2024
$2.9M
5,377 prescriptions
Company payments, 2025
$42K
From 39 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michelle D Welch was code 99214 (office e&m - established), 2,111 times for 718 patients. In total Michelle D Welch billed 6,721 services in 31 codes, and Medicare paid $382K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,111 | 718 | $90.57 | $191K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,947 | 474 | $47.86 | $93K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 908 | 471 | $12.24 | $11K |
| 95251 Test - Miscellaneous | Office | 495 | 208 | $25.80 | $13K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 434 | 337 | $36.56 | $16K |
| 76536 Ultrasound - Nonspecific | Office | 156 | 156 | $75.70 | $12K |
| 99212 Office E&M - Established | Office | 108 | 95 | $40.65 | $4,390 |
| 95250 Test - Miscellaneous | Office | 75 | 67 | $100.41 | $7,530 |
| 99457 E&M - Miscellaneous | Office | 67 | 31 | $36.11 | $2,419 |
| 99213 Office E&M - Established | Office | 65 | 63 | $65.16 | $4,235 |
| 95923 Electrical Nerve Conductivity | Office | 49 | 43 | $87.35 | $4,280 |
| 95921 Electrical Nerve Conductivity | Office | 49 | 43 | $65.11 | $3,191 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 42 | 29 | $47.27 | $1,985 |
| 76981 Ultrasound - Nonspecific | Office | 41 | 41 | $76.72 | $3,146 |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 34 | 32 | $102.74 | $3,493 |
By year: 2022 $256K for 3,198 services; 2023 $248K for 3,287 services; 2024 $382K for 6,721 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michelle D Welch prescribed most often to Medicare patients was Levothyroxine Sodium, with 541 prescriptions and refills. In total Michelle D Welch wrote 5,377 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 541 | 1,489 | 192 | $6,126 |
| Mounjaro Tirzepatide | 492 | 608 | 99 | $624K |
| Synthroid Levothyroxine Sodium | 395 | 1,005 | 137 | $37K |
| Rosuvastatin Calcium Generic | 274 | 794 | 105 | $3,222 |
| Ozempic Semaglutide | 243 | 326 | 67 | $301K |
| Jardiance Empagliflozin | 187 | 392 | 61 | $214K |
| Farxiga Dapagliflozin Propanediol | 162 | 354 | 53 | $188K |
| Trulicity Dulaglutide | 155 | 248 | 43 | $232K |
| Metformin Hcl Generic | 147 | 409 | 59 | $1,249 |
| Ezetimibe Generic | 124 | 354 | 47 | $3,617 |
| Metformin Hcl Er Metformin Hcl | 120 | 324 | 53 | $1,421 |
| Atorvastatin Calcium Generic | 102 | 274 | 53 | $778 |
| Liothyronine Sodium Generic | 88 | 242 | 35 | $4,161 |
| Tymlos Abaloparatide | 66 | 74 | Under 11 | $198K |
| Losartan Potassium Generic | 62 | 186 | 27 | $571 |
Brand drugs: 2,681 claims; generic drugs: 2,533 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michelle D Welch $42K ($42K in general payments such as food, travel and fees) from 39 companies. The largest payer was Lilly USA, LLC with $22K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.